Shares of this BioPharma on a Tear as it Successfully Engineered a T-Cell From a Healthy Human Donor
June 10 2024 - 2:30PM
AllPennyStocks.com
CAR T-cell therapy has seen significant growth and much promise,
as it provides targeted and personalized treatment for patients
with certain types of cancer, particularly those that have
not...
To read the full story on AllPennyStocks.com, click
here.
SOHM (PK) (USOTC:SHMN)
Historical Stock Chart
From Nov 2024 to Dec 2024
SOHM (PK) (USOTC:SHMN)
Historical Stock Chart
From Dec 2023 to Dec 2024
